---  
layout: startup_page  
title: "Windward Bio"  
id: "windwardbio.com"  
permalink: "/windwardbiowindwardbio.com01102025/"  
website: "https://www.windwardbio.com/"  
funding_round: "Series A"  
funding_amount: "$200M"  
investors: "OrbiMed, Novo Holdings, Blue Owl Healthcare Opportunities, SR One, Omega Funds, RTW Investments, Qiming Venture Partners, Quan Capital, Pivotal bioVenture Partners"  
about: "Windward Bio is a clinical-stage drug development company focused on improving outcomes for patients with advanced immunological diseases, initially targeting severe respiratory conditions. Their lead candidate, WIN378, is a long-acting monoclonal antibody aiming to reduce treatment burden, and they are also developing a pipeline of long-acting bispecifics."  
markets: "Biotechnology, Pharmaceuticals, Immunology, Life Science, Medical"  
hq: "Basel, Basel-Stadt, Switzerland"  
founded_year: "2024"  
linkedin: "https://www.linkedin.com/company/windward-bio-001"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/windward-bio"  
pitchbook: "https://pitchbook.com/profiles/company/731954-08"  

date_display: "10-Jan-2025"  
date: "2025-01-10"

# SEO Optimization  
meta_title: "Windward Bio - Series A Funding ($200M)"  
meta_description: "Windward Bio, Windward Bio is a clinical-stage drug development company focused on improving outcomes for patients with advanced immunological diseases, initially t..."  
meta_keywords: "Windward Bio, Biotechnology, Pharmaceuticals, Immunology, Life Science, Medical, Series A funding"  
canonical_url: "https://startup.projectstartups.com/windwardbiowindwardbio.com01102025/"  
---